- Home
- SXTC vs DBL Comparison
SXTC vs DBL Comparison
Compare SXTC & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- DBL
- Stock Information
- Founded
- SXTC 2005
- DBL 2011
- Country
- SXTC China
- DBL United States
- Employees
- SXTC N/A
- DBL N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- DBL
- Sector
- SXTC Health Care
- DBL
- Exchange
- SXTC Nasdaq
- DBL Nasdaq
- Market Cap
- SXTC 1.6M
- DBL 284.1M
- IPO Year
- SXTC 2019
- DBL N/A
- Fundamental
- Price
- SXTC $0.32
- DBL $15.33
- Analyst Decision
- SXTC
- DBL
- Analyst Count
- SXTC 0
- DBL 0
- Target Price
- SXTC N/A
- DBL N/A
- AVG Volume (30 Days)
- SXTC 1.7M
- DBL 61.0K
- Earning Date
- SXTC 01-01-0001
- DBL 01-01-0001
- Dividend Yield
- SXTC N/A
- DBL 8.67%
- EPS Growth
- SXTC N/A
- DBL N/A
- EPS
- SXTC N/A
- DBL N/A
- Revenue
- SXTC $1,928,497.00
- DBL N/A
- Revenue This Year
- SXTC N/A
- DBL N/A
- Revenue Next Year
- SXTC N/A
- DBL N/A
- P/E Ratio
- SXTC N/A
- DBL N/A
- Revenue Growth
- SXTC N/A
- DBL N/A
- 52 Week Low
- SXTC $0.30
- DBL $13.75
- 52 Week High
- SXTC $6.39
- DBL $15.70
- Technical
- Relative Strength Index (RSI)
- SXTC 33.98
- DBL 36.15
- Support Level
- SXTC $0.39
- DBL $15.42
- Resistance Level
- SXTC $0.36
- DBL $15.76
- Average True Range (ATR)
- SXTC 0.05
- DBL 0.12
- MACD
- SXTC -0.00
- DBL -0.02
- Stochastic Oscillator
- SXTC 7.97
- DBL 10.20
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.